# Prospective Evaluation of a New Palatal Implant for Treatment of Snoring and Obstructive Sleep Apnea (OSAS)

> **NCT02094482** · NA · COMPLETED · sponsor: **Medartis AG** · enrollment: 29 (actual)

## Conditions studied

- Reduction of Initial AHI
- Reduction of Initial Snoaring Index

## Interventions

- **DEVICE:** The IMD is a resilient palatal implant which is introduced through a stab incision into the palate.

## Key facts

- **NCT ID:** NCT02094482
- **Lead sponsor:** Medartis AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2020-07
- **Final completion:** 2020-10
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2021-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02094482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02094482, "Prospective Evaluation of a New Palatal Implant for Treatment of Snoring and Obstructive Sleep Apnea (OSAS)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02094482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*